Actively Recruiting

Phase Not Applicable
Age: 12Years - 16Years
All Genders
Healthy Volunteers
NCT06273137

Positive Affect Treatment for Adolescents With Early Life Adversity

Led by University of California, Irvine · Updated on 2026-05-06

300

Participants Needed

1

Research Sites

351 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Youth exposed to early life adversity (ELA) are known to be at greater risk for depression and suicidality and account for almost half of the youth suffering from psychiatric diseases today. Youth exposed to ELA consistently report symptoms of anhedonia as well as dysregulated positive affect. The present project will test the efficacy of PAT in a sample of ELA-exposed adolescents in order to determine whether PAT increases positive affect, and subsequently symptoms of depression. For the initial pilot phase of the investigation, the investigators will recruit up to 30 adolescents exposed to two or more childhood adversities (ACEs) who do not currently have major depressive disorder, and randomize them (1:1) to either participate in PAT or a waitlist control condition. For the second phase of the investigation, the investigators will recruit up to 300 adolescents exposed to two or more childhood adversities (ACEs) who do not currently have major depressive disorder, and randomize them (1:1) to either participate in PAT or supportive psychotherapy. For both phases, at study enrollment, then 4-, 8, and 12-months thereafter the investigators will measure positive affect and depressive symptoms (including anhedonia and reward sensitivity). The results of this study will be used to inform whether PAT has the potential to prevent major depressive episodes among adversity-exposed youth.

CONDITIONS

Official Title

Positive Affect Treatment for Adolescents With Early Life Adversity

Who Can Participate

Age: 12Years - 16Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Aged 12 to 16 years
  • Exposed to two or more adverse childhood experiences (ACEs)
Not Eligible

You will not qualify if you...

  • Currently taking an antidepressant or medications affecting immune function daily (e.g., steroids for asthma or allergies)
  • Current or past history of manic or psychotic symptoms
  • Parent-reported diagnosis of intellectual disability or autism spectrum disorder
  • Chronic medical conditions such as cancer, rheumatoid arthritis, diabetes, or multiple sclerosis
  • Bleeding disorders such as hemophilia

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of California Irvine

Irvine, California, United States, 92617

Actively Recruiting

Loading map...

Research Team

K

Kate R Kuhlman, Ph.D.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

PREVENTION

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here